Improving HPV vaccination for preteens ages 9-12
Part of Cancer, Infections clinical trials.
This study tests a program designed to help primary care practices increase HPV vaccination rates among adolescents aged 9 to 12 who haven't yet been vaccinated. It aims to find out if providing practices with resources and support can lead to more kids getting the HPV vaccine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child's doctor's office is a community-based primary care practice (pediatrics or family medicine).
- The practice is willing to participate in the study.
- The practice sees enough kids aged 9 to 12 (about 51 over 9 months).
- The practice uses electronic health records or reports to the state immunization system.
- Your child is between 9 and 12 years old.
- Your child visits an enrolled practice during the study.
- Your child has not yet received any doses of the HPV vaccine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether training pharmacy staff in communication and vaccination workflows can improve HPV vaccine recommendations and uptake. If you are a parent or guardian of a child aged 9–17 who has not yet completed the HPV vaccine series, you may be eligible to participate.
This trial tests a program to help community health centers recommend and boost HPV vaccination rates among Latino adolescents aged 11-12. It aims to support health care providers and staff with education and resources.
This study looks at ways to make it easier for preteens aged 10 to 12 to get the HPV vaccine, which protects against certain cancers. It aims to see if simple reminders or education can increase vaccination rates.
This study aims to help prevent HPV-related cancers by increasing HPV vaccination rates in rural areas. It is for parents of 8- to 12-year-olds who have not yet completed the two-dose HPV vaccine series.
This study tests whether real-time reminders and guidance help families stay on track with the HPV vaccine for children who are 11–12 years old. It’s a “feasibility” study, meaning it focuses on whether the approach is practical and acceptable.
This study looks at whether getting a provider recommendation helps more parents bring children ages 9–12 in for HPV vaccination. It may help increase vaccination uptake in pediatric clinics.
Hear when a new Human Papillomavirus-Related Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.